VITA 34 AG V3V.DE · Stock Open VITA 34 AG in new tab
VITA 34 AG Analysis (V3V.DE)
Is VITA 34 AG a good investment? VITA 34 AG (V3V.DE) is currently trading at 3.06 EUR.
Earnings Schedule: VITA 34 AG is expected to release its next earnings report on Nov. 30, 2026. The market consensus estimate for Forward EPS is 0.06.
Investor FAQ
Does VITA 34 AG pay a dividend?
No, it does not currently pay a dividend.
What asset class is VITA 34 AG?
VITA 34 AG is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Nov. 30, 2026. The company currently has a trailing EPS of -0.37.
Company Profile
FamiCord AG engages in the collection, processing, storage, and distribution of cells, tissues, blood, and blood components for medical applications in Germany, Poland, Switzerland, Portugal, and internationally. The company operates through Subgroup Vita 34 And Subgroup PBKM segments. It produces and develops advanced therapies, genetic tests, and analyses for third parties. The company also engages in the development and manufacture of cell and tissue-based products and pharmaceuticals, including the production of viral vectors or comparable products. In addition, it engages in research and development, storage, and cryopreservation of sperm and oocytes for use in reproductive medicine; and the manufacturing and distribution of medical devices. The company was formerly known as VITA 34 AG and changed its name to FamiCord AG in February 2025. FamiCord AG was founded in 1997 and is headquartered in Leipzig, Germany.
| Year | Total Dividends |
|---|---|
| ▸2019 |
0.16 EUR
|
| June 7, 2019 | 0.1600 |
| ▸2018 |
0.16 EUR
|
| May 18, 2018 | 0.1600 |
| ▸2017 |
0.16 EUR
|
| July 3, 2017 | 0.1600 |
| ▸2016 |
0.16 EUR
|
| Aug. 31, 2016 | 0.1600 |
| ▸2015 |
0.15 EUR
|
| July 29, 2015 | 0.1500 |
| Split Date | Split Ratio to 1 |
|---|---|
| July 14, 2017 | 1.03 |
Community Discussion